Efficacy of clorpactin('registered trademark (R)) in bladder pain syndrome/interstitial cystitis: a randomised placebo-controlled trial

Efficacy of clorpactin(R) in bladder pain syndrome/interstitial cystitis: a randomised placebo-controlled trial

Status

Completed

Phases

Phase 3

Study type

Interventional

Source

ANZCTR

Registry ID

ACTRN12611000717954

Enrollment

Registered

2011-07-11

Start date

2012-03-01

Completion date

2016-12-31

Last updated

2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

A randomised trial assessing the efficacy of Clorpactin instillation in women with Bladder pain syndrome/Interstitial cystitis

Interventions

Clorpactin (sodium oxychlorosene) 0.4% solution (2gm in 500ml sterile water) given as a single intravesical instillation under general anaesthetic

Study design

Allocation

Randomised controlled trial

Intervention model

Parallel

Primary purpose

Treatment

Masking

Blinded (masking used)

Eligibility

Sex/Gender

All

Age

18 Years to 70 Years

Healthy volunteers

Inclusion criteria

Females 18-70 years old Diagnosed with bladder pain syndrome/interstitial cystitis

Exclusion criteria

Allergy to clorpactin(R) or it’s constituent parts History of renal impairment or vesico-ureteric reflux Contraindication to general anaesthetic Unable to sign consent Unable to attend followup or complete questionnaires

Outcome results